Literature DB >> 16443701

Inhaled corticosteroids moderate lung function decline in adults with asthma.

P Ernst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16443701      PMCID： PMC2104573          DOI： 10.1136/thx.2005.042010

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  24 in total

1.  Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood.

Authors:  Finn Rasmussen; D Robin Taylor; Erin M Flannery; Jan O Cowan; Justina M Greene; G Peter Herbison; Malcolm R Sears
Journal:  Am J Respir Crit Care Med       Date:  2002-06-01       Impact factor: 21.405

2.  Long-term effects of budesonide or nedocromil in children with asthma.

Authors:  Stanley Szefler; Scott Weiss; James Tonascia; N Franklin Adkinson; Bruce Bender; Reuben Cherniack; Michele Donithan; H William Kelly; Joseph Reisman; Gail G Shapiro; Alice L Sternberg; Robert Strunk; Virginia Taggart; Mark Van Natta; Robert Wise; Margaret Wu; Robert Zeiger
Journal:  N Engl J Med       Date:  2000-10-12       Impact factor: 91.245

3.  Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids.

Authors:  L P Boulet; H Turcotte; M Laviolette; F Naud; M C Bernier; S Martel; J Chakir
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

4.  Inhaled corticosteroids and decline of lung function in community residents with asthma.

Authors:  P Lange; H Scharling; C S Ulrik; J Vestbo
Journal:  Thorax       Date:  2006-02       Impact factor: 9.139

5.  The early course of newly diagnosed asthma.

Authors:  Pierre Ernst; Bing Cai; Lucie Blais; Samy Suissa
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

6.  Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma.

Authors:  C S Ulrik; V Backer
Journal:  Eur Respir J       Date:  1999-10       Impact factor: 16.671

7.  Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study.

Authors:  M H Grol; J Gerritsen; J M Vonk; J P Schouten; G H Koëter; B Rijcken; D S Postma
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

Review 8.  Inhaled corticosteroids: impact on asthma morbidity and mortality.

Authors:  S Suissa; P Ernst
Journal:  J Allergy Clin Immunol       Date:  2001-06       Impact factor: 10.793

9.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.

Authors:  C Ward; M Pais; R Bish; D Reid; B Feltis; D Johns; E H Walters
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

10.  Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.

Authors:  R H Green; C E Brightling; G Woltmann; D Parker; A J Wardlaw; I D Pavord
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139
View more
  2 in total

1.  Inhaled corticosteroids and long term outcome in adults with asthma.

Authors:  P J F M Merkus; J C de Jongste
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 2.  Asthma progression and mortality: the role of inhaled corticosteroids.

Authors:  Paul O'Byrne; Leonardo M Fabbri; Ian D Pavord; Alberto Papi; Stefano Petruzzelli; Peter Lange
Journal:  Eur Respir J       Date:  2019-07-18       Impact factor: 16.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.